Orbit Genomics

Orbit Genomics, based in Boulder, Colorado, is at the forefront of transforming the diagnosis, treatment, and prevention of complex diseases such as cancer, heart disease, and neurological disorders through its innovative AI-driven OrbiSeq technology. This patented platform offers the first blood test capable of accurately diagnosing early-stage lung cancer, aiming to replace invasive procedures and facilitate timely intervention.

Founded through a collaboration between Dr. Harold Skip Garner and Ventac Partners, Orbit Genomics is dedicated to accelerating precision medicine and reducing the devastating impact of cancer. The company continues to build on two decades of research to develop clinically actionable products that enhance disease risk assessment and enable earlier interventions.

Generated from the website